Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

A Prospective Analysis of Potential and Observed Drug-Drug Interactions, Adverse Events and its Associated Risk Factors in Hospitalized Cardiology Patients in Benin

Author(s): Aurel C.E. Allabi*, Yessoufou Tchabi, Murielle Hounkponou, Rebecca Quenum and Jeanne Vehounkpe-Sacca

Volume 15, Issue 3, 2020

Page: [190 - 197] Pages: 8

DOI: 10.2174/1574886315666200621184913

Price: $65

Abstract

Background & Aims: The objective is to ascertain the pattern of potential drug-drug interactions (pDDIs) and record any observed DDIs and adverse events (AEs) in hospitalized Beninese cardiology patients from Sub-Saharan Africa and analyze all risk factors associated with DDIs and AEs.

Methods: It was a prospective study in which data including AEs were assessed from medical files and interview of patients and their relatives. Patients who were treated with more than two drugs and who remained in the hospital for at least 48 hours were included. A computerized database system Pharma IAM- VIDAL version 2011 was used to identify the pattern for potential DDIs.

Results: 156 patients were included in this study. The prevalence of potential DDIs was estimated at 93 % (145/156). Forty (5.1%) among 804 potential DDIs identified were observed clinically. The observed DDIs were attributable to low blood pressure (27.5%), hyponatremia (22.5%), hemorrhage (20.0%), hyperkalemia (17.5%) and nephrotoxicity (7.5%). The combination of spironolactone and furosemide resulted in hyponatremia while the combination of enoxaparin and potassium resulted in hyperkalemia. ACE inhibitor (or ARAII) in combination with furosemide resulted in the nephrotoxicity cases observed. Enoxaparin, Acetyl salicylic acid, Acenocoumarol and Clopidogrel were decreasingly involved in the pairs of drugs responsible for observed hemorrhages. 29 patients out of 156 (18.6%) had at least one AE. AEs were mainly (34.2%) of metabolic type. Severe AEs, which represented 18.4% was mostly from nephrotoxicity and metabolic disorders. More than 14 active substances multiplied the risk factor for AEs occurrence by 42, while more than 14 days hospitalization increased this risk by 42.

Conclusion: This study highlights the need to optimize treatments by strictly regulating blood pressure, serum sodium and potassium levels, coagulation parameters and looking for clinical signs of hemorrhage. Physician should be aware of certain drug associations that may carry a risk of severe adverse events.

Keywords: Drug-drug interaction, adverse event, hospitalized, cardiology, Benin, West Africa.

« Previous Next »
Graphical Abstract

[1]
Day RO, Snowden L, McLachlan AJ. Life-threatening drug interactions: What the physician needs to know. Intern Med J 2017; 47(5): 501-12.
[http://dx.doi.org/10.1111/imj.13404] [PMID: 28503886]
[2]
Mimica Matanović S, Vlahovic-Palcevski V. Potentially inappropriate medications in the elderly: A comprehensive protocol. Eur J Clin Pharmacol 2012; 68(8): 1123-38.
[http://dx.doi.org/10.1007/s00228-012-1238-1] [PMID: 22362342]
[3]
Golchin N, Frank SH, Vince A, Isham L, Meropol SB. Polypharmacy in the elderly. J Res Pharm Pract 2015; 4(2): 85-8.
[http://dx.doi.org/10.4103/2279-042X.155755] [PMID: 25984546]
[4]
Roughead EE, Kalisch LM, Barratt JD, Gilbert AL. Prevalence of potentially hazardous drug interactions amongst Australian veterans. Br J Clin Pharmacol 2010; 70(2): 252-7.
[http://dx.doi.org/10.1111/j.1365-2125.2010.03694.x] [PMID: 20653678]
[5]
Becker ML, Caspers PW, Kallewaard M, et al. Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands. Pharm World Sci 2007; 29(2): 51-7.
[http://dx.doi.org/10.1007/s11096-006-9061-3] [PMID: 17187223]
[6]
Elliott RA, Lee CY, Beanland C, Vakil K, Goeman D. Medicines management, medication errors and adverse medication events in older people referred to a community nursing service: A retrospective observational study. Drugs Real World Outcomes 2016; 3(1): 13-24.
[http://dx.doi.org/10.1007/s40801-016-0065-6] [PMID: 27747809]
[7]
Begaud B, Evreux JC, Jouglard J, Lagier G. Unexpected or toxic drug reaction assessment (Imputation) - actualization of the method used in France. Therapy 1985; 40: 115-8.
[8]
Hicham F, Youssef M, Mohamed RS, et al. Detection and analysis of drug–drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco. Pan Afr Med J 2018; 29: 225.
[9]
Sharma S, Chhetri HP, Alam K. A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal. Indian J Pharmacol 2014; 46(2): 152-6.
[http://dx.doi.org/10.4103/0253-7613.129303] [PMID: 24741184]
[10]
Jain S, Jain P, Sharma K, Saraswat P. A Prospective analysis of drug interactions in patients of intensive cardiac care unit. J Clin Diagn Res 2017; 11(3): FC01-4.
[http://dx.doi.org/10.7860/JCDR/2017/23638.9403] [PMID: 28511403]
[11]
Damorou F, Baragou S, Pio M, et al. Hospital-based morbidity and mortality from cardiovascular diseases in tropical areas: example of a hospital in Lome (Togo). Pan Afr Med J 2014; 17: 62.
[PMID: 25018812]
[12]
Patel VK, Acharya LD, Rajakannan T, Surulivelrajan M, Guddattu V, Padmakumar R. Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital. Australas Med J 2011; 4(1): 9-14.
[http://dx.doi.org/10.4066/AMJ.2011.450] [PMID: 23393498]
[13]
Fattinger K, Roos M, Vergères P, et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 2000; 49(2): 158-67.
[http://dx.doi.org/10.1046/j.1365-2125.2000.00132.x] [PMID: 10671911]
[14]
Doubova Dubova SV, Reyes-Morales H, Torres-Arreola Ldel P, Suárez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res 2007; 7: 147.
[http://dx.doi.org/10.1186/1472-6963-7-147] [PMID: 17880689]
[15]
Soukho-Kaya A, Minta DK, Diarra MT, et al. Undesirable effects of medicine in the Internal Medicine Service of the University Hospital Center du Point G. Mali Med 2010; 25(3): 10-4.
[PMID: 21441084]
[16]
Imbs JL, Pouyanne P, Haramburu F, et al. Regional centers of pharmacovigilance. Iatrogenic medication: Estimation of its prevalence in French public hospitals. Therapie 1999; 54(1): 21-7.
[PMID: 10216418]
[17]
Motter FR, Fritzen JS, Hilmer SN. Paniz eV, Paniz VMV. Potentially inappropriate medication in the elderly: A systematic review of validated explicit criteria. Eur J Clin Pharmacol 2018; 74(6): 679-700.
[http://dx.doi.org/10.1007/s00228-018-2446-0] [PMID: 29589066]

Rights & Permissions Print Cite
Article Metrics
59
© 2024 Bentham Science Publishers | Privacy Policy